Optimizing CD123-CAR T Cells for the Adoptive Immunotherapy of AML

被引:0
|
作者
Riberdy, Janice [1 ]
Zhou, Sheng [2 ]
Zheng, Fei [2 ]
Hoehamer, Young-In Kim [2 ]
Moore, Jennifer [1 ]
Vaidya, Abishek [1 ]
Throm, Robert [3 ]
Ryu, Byoung [3 ]
Gottschalk, Stephen [1 ]
Velasquez, Mireya Paulina [1 ]
机构
[1] St Jude Childrens Res Hosp, Bone Marrow Transplantat & Cellular Therapy, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Expt Cellular Therapy Lab, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Vector Dev, 332 N Lauderdale St, Memphis, TN 38105 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
580
引用
收藏
页码:271 / 272
页数:2
相关论文
共 50 条
  • [1] Adoptive immunotherapy of acute myeloid leukemia (AML) with allogenic CAR t-cells targeting CD123.
    Galetto, Roman
    Lebuhotel, Celine
    Francon, Patricia
    Gouble, Agnes
    Smith, Julianne
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] ALLOGENIC ADOPTIVE IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA (AML) BY TARGETING CD123 WITH CAR T-CELLS
    Galetto, R.
    Lebuhotel, C.
    Francon, P.
    Gouble, A.
    Smith, J.
    [J]. HAEMATOLOGICA, 2015, 100 : 172 - 172
  • [3] Allogenic CAR T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML)
    Galetto, Roman
    Lebuhotel, Celine
    Francon, Patricia
    Gouble, Agnes
    Smith, Julianne
    [J]. MOLECULAR THERAPY, 2015, 23 : S166 - S166
  • [4] AML IMMUNOTHERAPY WITH CD123-ENGAGER T CELLS
    Bonifant, Challice
    Torres, David
    Velasquez, Mireya
    Iwahori, Kota
    Arber, Caroline
    Song, Xiao-Tong
    Redell, Michele
    Gottschalk, Stephen
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : 22 - 22
  • [5] Allogenic T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML)
    Galetto, Roman
    Lebuhotel, Celine
    Gouble, Agnes
    Schiffer-Mannioui, Cecile
    Smith, Julianne
    [J]. BLOOD, 2014, 124 (21)
  • [6] TCRab Deficient CAR T-Cells Targeting CD123: An Allogeneic Approach of Adoptive Immunotherapy for the Treatment of Acute Myeloid Leukemia (AML)
    Galetto, Roman
    Lebuhotel, Celine
    Gouble, Agnes
    Mencia-Trinchant, Nuria
    Nicole, Cruz M.
    Roboz, Gail J.
    Guzman, Monica L.
    Smith, Julianne
    [J]. BLOOD, 2015, 126 (23)
  • [7] Mouse CD123-CAR T Cells Elicit Robust Anti-AML Activity without HSC Toxicity in Syngeneic Models
    Zoine, Jaquelyn T.
    Moore, Sarah E.
    Crawford, Jeremy C.
    Nevitt, Chris
    Langfitt, Deanna M.
    Barajas, Juan M.
    Abdelhamed, Sherif
    Iacobucci, Ilaria
    Michmerhuizen, Nicole L.
    Haydar, Dalia
    Krenciute, Giedre
    Mullighan, Charles G.
    Klco, Jeffery M.
    Gottschalk, Stephen
    Thomas, Paul G.
    Velasquez, M. Paulina
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 483 - 483
  • [8] Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
    Yi, Zhongzhen
    Prinzing, Brooke L.
    Cao, Felicia
    Gottschalk, Stephen
    Krenciute, Giedre
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 9 : 70 - 80
  • [9] CD123-CAR NK Cells are Activated by and Kill Acute Myeloid Leukemia
    Christodoulou, Ilias
    Marple, Andrew
    Ravich, Wesley
    Bonifant, Challice
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 151 - 151
  • [10] Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial
    Naik, Swati
    Madden, Renee M.
    Lipsitt, Amanda
    Lockey, Timothy
    Bran, Jennyfer
    Rubnitz, Jeffrey E.
    Klco, Jeffery
    Shulkin, Barry
    Patil, Sagar L.
    Schell, Sarah
    Park, Jeoungeun John
    Riberdy, Janice
    Shang, Na
    Zoine, Jaquelyn T.
    Wallace, Jennifer
    Harstead, Elaine
    Willis, Catherine
    Metais, Jean-Yves
    Langfitt, Deanna M.
    Zhou, Sheng
    Akel, Salem M.
    Meagher, Michael M.
    Triplett, Brandon M.
    Gottschalk, Stephen
    Velasquez, Mireya Paulina
    [J]. BLOOD, 2022, 140 : 4584 - 4585